Marijnen C A M, Kapiteijn E, van de Velde C J H, Martijn H, Steup W H, Wiggers T, Kranenbarg E Klein, Leer J W H
Department of Clinical Oncology, Leiden University Medical Center, Leiden, The Netherlands.
J Clin Oncol. 2002 Feb 1;20(3):817-25. doi: 10.1200/JCO.2002.20.3.817.
Total mesorectal excision (TME) surgery in the treatment of rectal cancer has been shown to result in a reduction in the number of local recurrences in retrospective studies. Reports on improved local control after preoperative, hypofractionated radiotherapy (RT) have led to the introduction of a prospective randomized multicenter trial, in which the effect of TME surgery with or without preoperative RT were evaluated. Any benefit in regard to a reduced local recurrence rate and possible improved survival must be weighed against potential adverse effects in both the short-term and the long-term. The present study was undertaken to assess the acute side effects of short-term, preoperative RT in rectal cancer patients and to study the influence of five doses of 5 Gy on surgical parameters, postoperative morbidity and mortality in patients randomized in the Dutch TME trial.
We analyzed 1,530 Dutch patients entered onto a prospective randomized trial, comparing preoperative RT with five doses of 5 Gy followed by TME surgery with TME surgery alone, of which 1,414 patients were assessable. Toxicity from RT, surgery characteristics, and postoperative complications and mortality were compared.
Toxicity during RT hardly occurred. Irradiated patients had 100 mL more blood loss during the operation (P <.001) and showed more perineal complications (P =.008) in cases of abdominoperineal resection. The total number of complications was slightly increased in the irradiated group (P =.008). No difference was observed in postoperative mortality (4.0% v 3.3%) or in the number of reinterventions.
Preoperative hypofractionated RT is a safe procedure in patients treated with TME surgery, despite a slight increase in complications when compared with TME surgery only.
回顾性研究表明,全直肠系膜切除术(TME)治疗直肠癌可减少局部复发的数量。关于术前短程分割放疗(RT)后局部控制改善的报道促使开展了一项前瞻性随机多中心试验,在该试验中评估了TME手术联合或不联合术前RT的效果。任何关于降低局部复发率和可能改善生存率的益处都必须与短期和长期的潜在不良反应相权衡。本研究旨在评估直肠癌患者短期术前RT的急性副作用,并研究荷兰TME试验中随机分组的患者接受五剂5 Gy放疗对手术参数、术后发病率和死亡率的影响。
我们分析了1530例参加前瞻性随机试验的荷兰患者,比较术前接受五剂5 Gy放疗后行TME手术与单纯TME手术的情况,其中1414例患者可进行评估。比较了放疗毒性、手术特征以及术后并发症和死亡率。
放疗期间几乎未出现毒性反应。接受放疗的患者手术期间失血多100 mL(P<.001),在腹会阴联合切除术中会阴部并发症更多(P=.008)。放疗组并发症总数略有增加(P=.008)。术后死亡率(4.0%对3.3%)或再次干预次数无差异。
术前短程分割放疗对接受TME手术的患者来说是一种安全的方法,尽管与单纯TME手术相比并发症略有增加。